Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway

References

• Karouzakis E, Neidhart M, Gay RE, Gay S. Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett. 2006;106:8–13.
   PubMed Web of Science ®Google Scholar
• Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MB, Wilder RL. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest. 1989;83:1267–76.
   Google Scholar
• Thornton SC, Por SB, Penny R, Richter M, Shelley L, Breit SN. Identification of the major fibroblast growth factors released spontaneously in inflammatory arthritis as platelet derived growth factor and tumor necrosis factor-alpha. Clin Exp Immunol. 1991;86:79–86.
   PubMed Web of Science ®Google Scholar
• Butler DM, Leizer T, Hamilton JA. Stimulation of human synovial fibroblast DNA synthesis by platelet-derived growth factor and fibroblast growth factor. Differences to the activation by IL-1. J Immunol. 1989;142: 3098–103.
   Google Scholar
• Goddard DH, Grossman SL, Newton R, Clark MA, Bomalaski JS. Regulation of synovial cell growth: basic fibroblast growth factor synergizes with interleukin 1 beta stimulating phospholi-pase A2 enzyme activity, phospholipase A2 activating protein production and release of prostaglandin E2 by rheumatoid arthritis synovial cells in culture. Cytokine. 1992;4: 377–84.
   Google Scholar
• Wilder RL, Lafyatis R, Roberts AB, Case JP, Kumkumian GK, Sano H, et al. Transforming growth factor-beta in rheumatoid arthritis. Ann N Y Acad Sci. 1990;593:197–207.
   PubMed Web of Science ®Google Scholar
• Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Kawabe Y, Aoyagi T, et al. Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor beta 1. Arthritis Rheum. 1996;39:1267–76.
   PubMedGoogle Scholar
• Lacey D, Sampey A, Mitchell R, Bucala R, Santos L, Leech M, et al. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum. 2003;48:103–9.
   PubMed Web of Science ®Google Scholar
• Rubin K, Terracio L, Rönnstrand L, Heldin CH, Klareskog L. Expression of platelet-derived growth factor receptors is induced on connective tissue cells during chronic synovial inflammation. Scand J Immunol. 1988;27:285–94.
   Google Scholar
• Remmers EF, Sano H, Lafyatis R, Case JP, Kumkumian GK, Hla T, et al. Production of platelet derived growth factor B chain (PDGF-B/c-sis) mRNA and immunoreactive PDGF B-like poly-peptide by rheumatoid synovium: coexpression with heparin binding acidic fibroblast growth factor-1. J Rheumatol. 1991;18:7–13.
   PubMed Web of Science ®Google Scholar
• Sano H, Engleka K, Mathern P, Hla T, Crofford LJ, Remmers EF, et al. Coexpression of phosphotyrosine-containing proteins, platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis. J Clin Invest. 1993;91:553–65.
   PubMed Web of Science ®Google Scholar
• Druker BJ. Imatinib as a paradigm of targeted therapies. Adv Cancer Res. 2004;91:1–30.
   PubMed Web of Science ®Google Scholar
• George D. Targeting PDGF receptors in cancer-rationales and proof of concept clinical trials. Adv Exp Med Biol. 2003;532:141–51.
   PubMed Web of Science ®Google Scholar
• Kitano M, Hla T, Sekiguchi M, Kawahito Y, Yoshimura R, Miyazawa K, et al. Sphingosine 1-phosphate/S1P1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum. 2006;54:742–53.
   PubMed Web of Science ®Google Scholar
• Sano H, Hla T, Maier JA, Crofford LJ, Case JP, Maciag T, et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest. 1992;89:97–108.
   PubMed Web of Science ®Google Scholar
• Kawahito Y, Kondo M, Tsubouchi Y, Hashiramoto A, Bishop-Bailey D, Inoue K, et al. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest. 2000;106: 189–97.
   Google Scholar
• Smeets TJ, Kraan MC, van Loon ME, Tak PP. Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue. Arthritis Rheum. 2003;48:2155–62.
   PubMed Web of Science ®Google Scholar
• Kramer I, Wibulswas A, Croft D, Genot E. Rheumatoid arthritis: targeting the proliferative fibroblasts. Prog Cell Cycle Res. 2003;5:59–70.
   Google Scholar
• Paniagua RT, Sharpe 0, Ho PP, Chan SM, Chang A, Higgins JP, et al. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J Clin Invest. 2006;116:2633–42.
   Google Scholar
• Ando W, Hashimoto J, Nampei A, Tsuboi H, Tateishi K, Ono T, et al. Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA). J Bone Miner Metab. 2006;24:274–82.
   PubMed Web of Science ®Google Scholar
• Koyama K, Hatsushika K, Ando T, Sakuma M, Wako M, Kato R, et al. Imatinib mesylate both prevents and treats the arthritis induced by type II collagen antibody in mice. Mod Rheumatol. 2007;17(4):306–10.
   PubMedGoogle Scholar
• Qu Z, Picou M, Dang TT, Angell E, Planck SR, Hart CE, et al. Immunolocalization of basic fibroblast growth factor and platelet-derived growth factor-A during adjuvant arthritis in the Lewis rat. Am J Pathol. 1994;145:1127–39.
   PubMed Web of Science ®Google Scholar
• Sakuma M, Hatsushika K, Koyama K, Katoh R, Ando T, Watanabe Y, et al. TGF-beta type I receptor kinase inhibitor down-regulates rheumatoid synoviocytes and prevents the arthritis induced by type II collagen antibody. Int Immunol. 2007;19:117–26.
   PubMed Web of Science ®Google Scholar
• Heldin CH, Westermark B. Signal transduction by the receptors for platelet-derived growth factor. J Cell Sci. 1990;96:193–6.
   PubMedGoogle Scholar
• Heldin CH, Eriksson U, Ostman A. New members of the platelet-derived growth factor family of mitogens. Arch Biochem Bio-phys. 2002;398:284–90.
   Google Scholar
• Petti LM, Ricciardi EC, Page HJ, Porter KA. Transforming signals resulting from sustained activation of the PDGF /3 receptor in mortal human fibroblasts. J Cell Sci. 2008;121: 1172–82.
   PubMed Web of Science ®Google Scholar
• Taylor CC. Platelet-derived growth factor activates porcine thecal cell phosphatidylinosito1-3-kinase-Akt/PKB and Ras-extracellu-lar signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor. Endocrinology. 2000;141:1545–53.
   Google Scholar
• Hayashi K, Takahashi M, Kimura K, Nishida W, Saga H, Sobue K. Changes in the balance of phosphoinositide 3-kinase/ protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol. 1999;145:727–40.
   PubMed Web of Science ®Google Scholar
• Kallin A, Demoulin JB, Nishida K, Hirano T, Rönnstrand L, Heldin CH. Gabl contributes to cytoskeletal reorganization and chemotaxis in response to platelet-derived growth factor. J Biol Chem. 2004;279:17897–904.
   Google Scholar
• Li W, Nishimura R, Kashishian A, Batzer AG, Kim WJ, Cooper JA, et al. A new function for a phosphotyrosine phosphatase: finking GRB2-Sos to a receptor tyrosine kinase. Mol Cell Biol. 1994;14:509–17.
   PubMed Web of Science ®Google Scholar
• DeMali KA, Balciunaite E, Kazlauskas A. Integrins enhance platelet-derived growth factor (PDGF)-dependent responses by altering the signal relay enzymes that are recruited to the PDGF beta receptor. J Biol Chem. 1999;274:19551–8.
   Google Scholar
• Sandler C, Joutsiniemi S, Lindstedt KA, Juutilainen T, Kovanen PT, Eklund KK. Imatinib mesylate inhibits platelet derived growth factor stimulated proliferation of rheumatoid synovial fibroblasts. Biochem Biophys Res Commun. 2006;347:31–5.
   Google Scholar
• Kameda H, Ishigami H, Suzuki M, Abe T, Takeuchi T. Imatinib mesylate inhibits proliferation of rheumatoid synovial fibroblast-like cells and phosphorylation of Gab adapter proteins activated by platelet-derived growth factor. Clin Exp Immunol. 2006;144: 335–41.
   Google Scholar
• Juurikivi A, Sandler C, Lindstedt KA, Kovanen PT, Juutilainen T, Leskinen MJ, et al. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis. Ann Rheum Dis. 2005;64:1126–31.
   PubMed Web of Science ®Google Scholar
• Miyachi K, Ihara A, Hankins RW, Murai R, Maehiro S, Miyashita H. Efficacy of imatinib mesylate (STI571) treatment for a patient with rheumatoid arthritis developing chronic mye-logenous leukemia. Clin Rheumatol. 2003;22:329–32.
   PubMed Web of Science ®Google Scholar
• Eklund KK, Joensuu H. Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases. Ann Med. 2003;35:362–7.
   PubMed Web of Science ®Google Scholar
• Eklund KK, Lindstedt K, Sandler C, Kovanen PT, Laasonen L, Juurikivi A, et al. Maintained efficacy of the tyrosine kinase inhibitor imatinib mesylate in a patient with rheumatoid arthritis. J Clin Rheumatol. 2008;14(5):294–6.
   Google Scholar
• Ames PR, Aye WW, Beatty C, O'Reilly D. Imatinib treatment of seropositive arthritis in a young woman with chronic myeloid leukemia. J Rheumatol. 2008;35(8):1682.
   Google Scholar